Quantification of von Willebrand Factor and von Willebrand Factor Propeptide in Patients with End Stage Renal Disease

被引：0

作者：

Davis, Rachael ^{[1
]}

Bansal, Vinod ^{[1
]}

Litinas, Evangelos ^{[1
]}

Rahman, Saudur ^{[1
]}

Hoppensteadt, Debra ^{[1
]}

Conway, Brooke ^{[2
]}

Fareed, Jawed ^{[1
]}

机构：

[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA

[2] GTI Diagnost, Waukesha, WI USA

来源：

FASEB JOURNAL | 2010年 / 24卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：1

共 50 条

[21] von Willebrand disease and quantitative variation in von Willebrand factor [J].

Mohlke, KL ;

Ginsburg, D .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (03) :252-261

[22] Association of malaria severity with von Willebrand factor and von Willebrand factor propeptide levels and blood group. [J].

Donkor, C ;

Hollestelle, MJ ;

Akoto, AO ;

O'Donnell, J ;

van Mourik, JA ;

Bunn, J .

BLOOD, 2003, 102 (11) :71B-71B

[23] Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival [J].

Haberichter, Sandra L. ;

Balistreri, Michael ;

Christopherson, Pamela ;

Morateck, Patricia ;

Gavazova, Stefana ;

Bellissimo, Daniel B. ;

Manco-Johnson, Marilyn J. ;

Gill, Joan Cox ;

Montgomery, Robert R. .

BLOOD, 2006, 108 (10) :3344-3351

[24] Phenotype IIC von Willebrand disease: In ''cis'' or in ''trans'' impact of propeptide mutations on von Willebrand factor multimerization? [J].

Gaucher, C ;

Mazurier, C .

THROMBOSIS AND HAEMOSTASIS, 1997, :P1490-P1490

[25] INHIBITION OF WILLEBRAND FACTOR IN VON WILLEBRAND DISEASE [J].

MARAGALL, S ;

CASTILLO, R ;

ORDINAS, A ;

LIENDO, F ;

RODRIGUEZ, M .

THROMBOSIS RESEARCH, 1979, 14 (2-3) :495-500

[26] VON-WILLEBRAND-FACTOR BINDING TO COLLAGEN IN PATIENTS WITH END-STAGE RENAL-DISEASE [J].

NIESVIZKY, R ;

CALANDRI, C ;

PATEL, ND ;

ZHOU, SL ;

POTTER, BJ ;

RAND, JH .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 123 (01) :137-142

[27] Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome [J].

van Genderen, PJJ ;

Boertjes, RC ;

van Mourik, JA .

THROMBOSIS AND HAEMOSTASIS, 1998, 80 (03) :495-498

[28] The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy [J].

Delbrueck, Christiane ;

Miesbach, Wolfgang .

ACTA HAEMATOLOGICA, 2019, 142 (02) :71-78

[29] PHARMACOKINETIC MODELING OF THE VON WILLEBRAND FACTOR - FACTOR VIII INTERACTION IN PERIOPERATIVE VON WILLEBRAND DISEASE PATIENTS [J].

Bukkems, L. H. ;

Heijdra, J. ;

de Jager, N. ;

Hazendonk, H. ;

Fijnvandraat, K. ;

Meijer, K. ;

Eikenboom, J. ;

Laros-van Gorkom, B. ;

Leebeek, F. ;

Cnossen, M. ;

Mathot, R. .

HAEMOPHILIA, 2021, 27 :147-147

[30] Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease [J].

Bukkems, Laura H. ;

Heijdra, Jessica M. ;

de Jager, Nico C. B. ;

Hazendonk, Hendrika C. A. M. ;

Fijnvandraat, Karin ;

Meijer, Karina ;

Eikenboom, Jeroen C. J. ;

Laros-van Gorkom, Britta A. P. ;

Leebeek, Frank W. G. ;

Cnossen, Marjon H. ;

Mathot, Ron A. A. .

BLOOD ADVANCES, 2021, 5 (05) :1513-1522

← 1 2 3 4 5 →